Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 16 studies | 64% ± 17% | |
| oligodendrocyte precursor cell | 11 studies | 31% ± 12% | |
| epithelial cell | 4 studies | 32% ± 12% | |
| kidney loop of Henle epithelial cell | 4 studies | 28% ± 6% | |
| renal alpha-intercalated cell | 4 studies | 28% ± 5% | |
| enteroendocrine cell | 3 studies | 19% ± 4% | |
| brush cell | 3 studies | 24% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 37% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 98% | 5473.11 | 2602 / 2642 | 91% | 81.38 | 645 / 705 |
| kidney | 100% | 1745.36 | 89 / 89 | 86% | 27.27 | 776 / 901 |
| pancreas | 93% | 533.39 | 306 / 328 | 87% | 20.69 | 154 / 178 |
| stomach | 73% | 765.23 | 261 / 359 | 92% | 35.40 | 263 / 286 |
| intestine | 46% | 912.67 | 444 / 966 | 97% | 47.21 | 513 / 527 |
| thymus | 78% | 453.39 | 511 / 653 | 22% | 3.54 | 136 / 605 |
| esophagus | 5% | 21.21 | 76 / 1445 | 79% | 29.96 | 144 / 183 |
| ovary | 0% | 0 | 0 / 180 | 69% | 10.83 | 296 / 430 |
| lung | 2% | 6.31 | 10 / 578 | 63% | 14.88 | 727 / 1155 |
| uterus | 9% | 39.04 | 15 / 170 | 47% | 11.88 | 218 / 459 |
| skin | 4% | 16.11 | 75 / 1809 | 44% | 10.72 | 210 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 44% | 9.50 | 20 / 45 |
| bladder | 0% | 0 | 0 / 21 | 42% | 16.39 | 212 / 504 |
| breast | 20% | 98.41 | 90 / 459 | 17% | 5.39 | 190 / 1118 |
| lymph node | 0% | 0 | 0 / 0 | 31% | 3.40 | 9 / 29 |
| spleen | 31% | 118.44 | 74 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 0 | 0 / 258 | 7% | 0.95 | 17 / 230 |
| liver | 0% | 0 | 0 / 226 | 4% | 0.66 | 17 / 406 |
| blood vessel | 3% | 13.11 | 38 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 2% | 11.71 | 28 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 2% | 10.75 | 21 / 929 | 0% | 0 | 0 / 0 |
| prostate | 1% | 2.89 | 2 / 245 | 1% | 0.08 | 4 / 502 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.12 | 1 / 80 |
| muscle | 0% | 0.37 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0048812 | Biological process | neuron projection morphogenesis |
| GO_0035902 | Biological process | response to immobilization stress |
| GO_0002175 | Biological process | protein localization to paranode region of axon |
| GO_0030913 | Biological process | paranodal junction assembly |
| GO_0007010 | Biological process | cytoskeleton organization |
| GO_0006688 | Biological process | glycosphingolipid biosynthetic process |
| GO_0007422 | Biological process | peripheral nervous system development |
| GO_0006682 | Biological process | galactosylceramide biosynthetic process |
| GO_0007417 | Biological process | central nervous system development |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0003851 | Molecular function | N-acylsphingosine galactosyltransferase |
| GO_0008489 | Molecular function | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity |
| Gene name | UGT8 |
| Protein name | UDP glycosyltransferase 8 2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase) |
| Synonyms | UGT4 CGT |
| Description | FUNCTION: Catalyzes the transfer of galactose to ceramide, a key enzymatic step in the biosynthesis of galactocerebrosides, which are abundant sphingolipids of the myelin membrane of the central nervous system and peripheral nervous system . Galactosylates both hydroxy- and non-hydroxy fatty acid-containing ceramides and diglycerides (By similarity). . |
| Accessions | Q16880 ENST00000310836.11 D6RFW2 ENST00000394511.3 ENST00000507710.1 |